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Abstract
Objective: To determine whether metabolic syndrome traits influence the postprandial lipemia response of coronary
patients, and whether this influence depends on the number of MetS criteria.
Materials and Methods: 1002 coronary artery disease patients from the CORDIOPREV study were submitted to an oral fat
load test meal with 0.7 g fat/kg body weight (12% saturated fatty acids, 10% polyunsaturated fatty acids, 43%
monounsaturated fatty acids), 10% protein and 25% carbohydrates. Serial blood test analyzing lipid fractions were drawn at
0, 1, 2, 3 and 4 hours during the postprandial state. Total and incremental area under the curves of the different
postprandial parameters were calculated following the trapezoid rule to assess the magnitude of change during the
postprandial state
Results: Postprandial lipemia response was directly related to the presence of metabolic syndrome. We found a positive
association between the number of metabolic syndrome criteria and the response of postprandial plasma triglycerides (p,
0.001), area under the curve of triglycerides (p,0.001) and incremental area under the curve of triglycerides (p,0.001).
However, the influence of them on postprandial triglycerides remained statistically significant only in those patients without
basal hypertriglyceridemia. Interestingly, in stepwise multiple linear regression analysis with the AUC of triglycerides as the
dependent variable, only fasting triglycerides, fasting glucose and waist circumference appeared as significant independent
(P,0.05) contributors. The multiple lineal regression (R) was 0.77, and fasting triglycerides showed the greatest effect on
AUC of triglycerides with a standardized coefficient of 0.75.
Conclusions: Fasting triglycerides are the major contributors to the postprandial triglycerides levels. MetS influences the
postprandial response of lipids in patients with coronary heart disease, particularly in non-hypertriglyceridemic patients.
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Introduction
The postprandial state is the period from food intake to post-
absorptive state, defined in terms of extent and duration of
increased plasma triglycerides (TG) in response to fat intake. It is a
dynamic condition, with a continuous fluctuation in the degree of
lipemia and glycemia over the day, in which there is a rapid
continuous remodeling of the lipoprotein and a host of other
metabolic adaptations compared to the relatively stable conditions
in the fasting state. Over the last decade, postprandial triglyceride
metabolism has taken on more importance, since fasting is not the
typical physiological state of humans in modern society, who spend
most of the time in the postprandial state. In this context, the
evaluation of the postprandial lipemic response may be more
important to identify disturbances in lipid metabolism than
measurements taken in the fasting state. In fact, large population
studies (e.g. Women’s Health Study and the Copenhagen City
Heart Study) have assessed the association between non-fasting
triglycerides and the risk of cardiovascular disease (CVD) events.
Data from these studies have clearly documented that postprandial
TG levels are excellent markers of risk for coronary artery disease,
peripheral vascular disease and cerebrovascular disease [1–5]. In
this regard, it has been proposed that non-fasting TG (5 mmol/L
vs. ,1 mmol/L) marked a 17- and 5-fold increased risk of
myocardial infarction, a 5-and 3-fold increased risk of ischemic
stroke, and a 4- and 2-fold increased risk of early death in women
and men in the general population [1–4].
Moreover, several studies have linked the extent of postprandial
lipemia to the incidence of coronary heart disease and it has been
proposed that postprandial lipoprotein metabolism is modulated
by dietary patterns, food composition, conditions associated with
lifestyle (physical activity, smoking and alcohol consumption),
physiological factors (age, gender, genetic background and
postmenopausal status) and cardiometabolic conditions such as
fasting triglycerides levels [6–10], type 2 diabetes (T2DM), insulin
resistance and obesity [11–13].
The importance of Metabolic Syndrome (MetS) lies in its close
association with the risk of CVD and T2DM. Unfortunately its
prevalence is increasing to epidemic proportions and the health
care costs and burden are substantial. One of the most widely
accepted definitions is that provided by the National Cholesterol
Education Program guidelines, revised in 2004 (rNCEP) [14]. In a
recent meta-analysis [15], including 952.083 patients and carried
out to assess the prognostic significance of MetS in cardiovascular
disease, it was shown that MetS was associated with a 2-fold
increase in cardiovascular outcomes (cardiovascular disease,
cardiovascular mortality, myocardial infarction and stroke) and a
1.5-fold increase in all-cause mortality. In turn, excluding the
influence of the presence of T2DM, this increased risk persists for
cardiovascular mortality, acute myocardial infarction and stroke.
These data confirmed previously published evidence [16]. From a
clinical point of view, there is a debate as to whether the MetS
alone or its associated conditions are more important for CVD
incidence and mortality or whether prevention and/or treatment
of the MetS will reduce CVD incidence and mortality. In this
regard, previous observations have reported that the presence of
more components of MetS was associated with an increase in
subclinical atherosclerosis, and incidence and mortality of
coronary heart disease [17–21]. In the same context, it has been
suggested that, in healthy people, there is a relationship between
MetS components and exacerbated postprandial lipemia [22], but
there is still a lack of data in patients with CVD.
Based on this previous evidence, our objective was to determine
if MetS traits influence the postprandial lipemia of coronary




Patients gave written informed consent to participate in the
study. The trial protocol and all amendments were approved by
the Ethics Committee from Reina Sofia University Hospital,
following the Declaration of Helsinki (2008) of the World Medical
Association.
Population
The current work was conducted within the framework of the
CORDIOPREV study. The CORDIOPREV study is an ongoing
prospective, randomized, opened, controlled trial including 1002
patients with coronary heart disease (CHD), who had their last
coronary event more than six months before enrollment in two
different dietary models (Mediterranean and low-fat) over a period
of five years, in addition to conventional treatment for CHD.
Patients were recruited from November 2009 to February 2012,
mostly at the Reina Sofia University Hospital (Cordoba, Spain),
but patients from other hospital centers from the Cordoba and
Jaen provinces were also admitted.
Inclusion and exclusion criteria are shown in Table 1. In
summary, patients were eligible if they were between 20 and 75,
had established CHD without clinical events in the last six months,
were thought to follow a long-term dietary intervention and had
no severe diseases or an expected life expectancy of under five
years. Patients were categorized depending on the presence or not
of MetS and number of its criteria, defined by the rNCEP criteria
[14].
Study design
Before participants were enrolled in the two different dietary
models from CORDIOPREV study, they received an oral fat
tolerance test using a weight-adjusted meal (0.7 g fat and 5 mg
cholesterol per kg body weight) with 12% saturated fatty acids
(SFA), 10% polyunsaturated fatty acids (PUFA), 43% monoun-
saturated fatty acids (MUFA), 10% protein and 25% carbohy-
drates (CHO). The meal composition was designed by a group of
nutritionists with olive oil, skimmed milk, white bread, cooked egg
yolks and tomatoes.
Methodology of the oral fat tolerance test
Before starting the test, the patients had fasted (food/drugs) for
12 hours and were asked to refrain from smoking during the
fasting period and from alcohol intake during the preceding 7
days. They were also asked to avoid strenuous physical activity the
day before the test was given. The patients arrived at the clinical
center at 08:00 h. We measured anthropometric (weight, height,
waist circumference, Body mass index (BMI) and blood pressure)
and biochemical measurements, took a fasting blood sample and
under supervision, the patients ingested the fatty food meal. The
breakfast was eaten in 20 min. After the meal, the volunteers
rested and consumed no food for 5 hours, but were allowed to
drink water.
Blood samples for biochemical testing were collected before the
meal and every hour during the next 4 hours, following
recommendations for an oral fat tolerance test proposed by Mihas
et al. in a recent meta-analysis [23].
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Table 1. Inclusion and exclusion criteria for the CORDIOPREV study.
Ages
Eligible for






Unstable Coronary Disease Chronic
Acute Myocardial Infarction
Unstable Angina
Chronic Coronary Disease with high risk of event
Exclusion
Criteria
Age ,20 or .75 (or life expectancy below 5 years)
Patients already scheduled for revascularization Patients submitted to revascularization in the last 6 months Grade II/IV Heart failure
Left ventricle dysfunction with ejection fraction lower than 35%
Patients unable to follow a protocol
Patients with severe uncontrolled Diabetes Mellitus, or those with Renal Insufficiency with permanent plasma creatinine higher than 2 mg/dl, or cerebral
complications of Diabetes Mellitus
Other chronic diseases: Psychiatric diseases, Chronic Renal Insufficiency, Chronic Hepatopathy, Active Malignancy, Chronic Obstructive Pulmonary
Disease, Diseases of the digestive tract, Endocrine disorders, Patients participating in other clinical trials (at the time of enrollment or 30 days before)
doi:10.1371/journal.pone.0096297.t001
Figure 1. Flow-chart of CORDIOPREV study. Before participants were enrolled in the two different dietary models from CORDIOPREV study, they
received an oral fat tolerance test using a weight-adjusted meal (0.7 g fat and 5 mg cholesterol per kg body weight) with 12% saturated fatty acids
(SFA), 10% polyunsaturated fatty acids (PUFA), 43% monounsaturated fatty acids (MUFA), 10% protein and 25% carbohydrates (CHO).
doi:10.1371/journal.pone.0096297.g001
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Laboratory test
Venous blood was sampled from the antecubital vein and
collected into tubes with no anticoagulant and EDTA, and
immediately transferred to 4uC. To minimize proteolytic degra-
dation, plasma was supplemented with protease inhibitor cocktail
40 mL per mL of plasma. Plasma and serum samples were frozen
at 280uC for further biochemical analysis.
Serum parameters were measured using spectrophotometric
techniques (enzymatic colorimetric methods): hexokinase method
for glucose, and oxidation-peroxidation for total cholesterol, HDL-
Table 2. Baseline characteristics of the patients.
All patients Metabolic Syndrome Non-Metabolic Syndrome p-value
(n = 1002) (n = 581) (n = 421)
Age (Years) 59.560.2 60.060.3 58.960.4 NS
Male/Female 837/165 470/111 367/54 ,0.001
Weight (Kg) 85.160.4 88.860.6 80.160.6 ,0.001
Waist circumference 105.160.3 108.760.4 100.160.5 ,0.001
BMI (kg/m2) 31.160.1 32.460.1 29.360.2 ,0.001
HDL-c (mg/dL) 42.260.3 38.660.4 47.160.5 ,0.001
Fasting Plasma Glucose (mg/dL) 113.761.2 125.961.8 97.161.0 ,0.001
TG (mg/dL) 135.462.2 159.963.1 102.162.2 ,0.001
APO-A1 (mg/dL) 129.660.7 124.960.8 136.161.1 ,0.001
Total Cholesterol (mg/dL) 159.060.9 158.661.3 159.561.4 NS
APO-B (mg/dL) 73.660.5 76.160.8 70.260.8 ,0.001
LDL-c (mg/dL) 88.560.8 86.3761.1 91.561.2 ,0.001
Lipid lowering drugs:
Statins (%) 85.6 85.7 85.5 NS
Fibrates (%) 1.6 2.4 0.5 0.01
Other1(%) 4.8 4.6 4.9 NS
Values are means 6SEM. Continuous variables were compared using the analysis of variance (ANOVA). Qualitative variables were compared using Chi Square test.
BMI = Body mass index. HDL-c = High density lipoprotein cholesterol. TG = Triglycerides. LDL-c = Low density lipoprotein.
1Other lipid lowering drugs: Ezetimibe and Nicotinic acid.
doi:10.1371/journal.pone.0096297.t002
Figure 2. Plasma levels of triglycerides (mg/dL) during postprandial period in patients with and without MetS. MetS patients showed
higher plasma levels of triglycerides in each of the time points performed during the postprandial period (p,0.001). Results are plotted as Mean6SE.
Variables were compared using repeated measured ANOVA, with sex and age as covariates.
doi:10.1371/journal.pone.0096297.g002
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cholesterol and triglycerides. The LDL-cholesterol was calculated
using the Friedewald formula (provided the triglyceride level was
less than 300 mg/dl). Apolipoprotein A1 and apolipoprotein B
were determined by immunoturbidimetry by means of mouse
specific antibodies for every magnitude.
TG-rich lipoprotein fraction (TRL) containing chylomicrons
and VLDL was removed from plasma by ultracentrifugation
performed in a 70Ti fixed-angle rotor at 30.000 rpm and 4uC for
30 min. at d,1.006 g/mL.
Statistical
All statistical analyses were made with PASW Statistics software,
version 18.0.0. Continuous variables were compared using
Student’s ‘‘t’’ and the analysis of variance (ANOVA) depending
on the existence of two or more groups in each comparison. When
these variables did not follow a normal distribution, the required
transformation of the data was used for analysis. We used total
(AUC) and incremental (iAUC) area under the curves of the
different postprandial parameters following the trapezoid rule to
assess the magnitude of change during the postprandial state, as in
previous works by our group [24]. The units used for the AUC
and iAUC were (mg * min * dL21). To determine the influence of
metabolic syndrome in the postprandial metabolism, we used a
general linear model of repeated measures of each postprandial
parameter, with presence or not of metabolic syndrome as a
between-subjects variable, blood drawing time as a within-subject
variable and gender and age as covariates. Bonferroni’s correction
was used for multiple comparisons. Pearson’s correlation or
Spearman rank order correlation analyses were performed to
examine the correlations between the levels of metabolic syndrome
traits (Systolic blood pressure, Diastolic Blood Pressure, HDL-c,
TG, Glucose and waist circumference), treatment (statins and
fibrates) and AUC of postprandial parameters. The values of
fasting triglycerides, fasting glucose, fasting HDL-c, waist circum-
ference and both systolic and diastolic blood pressure were tested
in a stepwise multiple linear regression to predict the AUC of
triglycerides and determine their individual effect on it.
Results
Baseline characteristics
A total of 1002 participants with coronary artery disease were
included in the CORDIOPREV study (Figure 1), of which 581
had MetS criteria.
Table 2 shows the baseline characteristics. The mean age was
59.5 years for all the population. They were mostly males (83.4%)
with a mean body mass index of 31.1 Kg/m2. Patients with MetS
showed significant differences compared with patients without
MetS, with greater weight, waist circumference, body mass index,
plasma glucose, and higher levels of fasting TG and ApoB (all, p,
0.05). MetS patients showed lower levels of fasting HDL-c, ApoA1
and LDL-c (all, p,0.05).
Postprandial parameters and Metabolic Syndrome
After the intake of the fat load test, we found differences
between patients with and without MetS during the postprandial
period. MetS patients showed higher plasma levels of TG
(Figure 2) and ApoB as well as lower HDL-c and ApoA1 in
each of the time points performed during the postprandial period
(all, p#0.001). No differences were detected for total cholesterol
between groups. Furthermore, MetS patients showed lower AUC
of postprandial HDL-c (8375.6684.6 vs 9940.5699.8, p,0.001)
and ApoA1 (28236.16205.7 vs 30546.96242.9, p,0.001), with
higher AUC of postprandial TG (55048.7461186.7 vs 36373.
661398.3, p,0.001), TRL (22389.36606.9 vs 13983.46703.1,
p,0.001), ApoB (16697.46176.8 vs 15289.76207.7, p,0.001)
and glucose (36936.76568.4 vs 27546.36669.5, p,0.001). We
also analyzed the incremental (iAUC) of area under postprandial
parameters curve. MetS patients showed higher iAUC of TG
(15298.96540.1 vs 12296.26636.4, p,0.001), TRL
(12673.16353.6 vs 9322.56409.6) and glucose (5608.06286.7
vs 2131.96337.6, p,0.001), with higher negative iAUC of ApoB
(2743.2668.4 vs 2490.2680.3, p,0.001) and total cholesterol
(21143.3692.9 vs 2828.56109.8, p,0.001).
Figure 3. Postprandial AUC of triglycerides in relation to Mets traits. The magnitude of the AUC of postprandial TG increased in the
sequence 0, 1,2 criteria ,3 criteria ,4 criteria ,5 criteria. Variables were compared using ANOVA with sex and age as covariates. Different letters
express statistically significant differences with a p value below 0.01.
doi:10.1371/journal.pone.0096297.g003
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Components of Metabolic Syndrome and postprandial
response
Postprandial lipemia response was directly related to the
number of MetS components. Specifically, we found a positive
association between the number of MetS criteria and the response
of postprandial plasma TG (p,0.001), AUC of TG (p,0.001) and
iAUC of TG (0,0.001). Interestingly, the magnitude of the AUC
of TG increased in the sequence 0, 1,2 criteria ,3 criteria ,4
criteria ,5 criteria, as shown in Figure 3 (p,0.001). For the
iAUC of TG, this sequence differs as follows: 0, 1,2, 3,4,5
(1017961862, 105016828,137466641, 137746633,
158866653,1900661070, respectively). A similar fashion was
detected for AUC of plasma glucose and ApoB. In contrast, a
negative relationship in the number of criteria of MetS with AUC
of HDL-c and ApoA1 was observed (data not shown).
The correlations between the levels of MetS traits and
postprandial parameters (AUCs of TG, TRL, total cholesterol,
HDL-c, ApoA1, ApoB and glucose) are shown in Table 3.
Specifically, postprandial AUC of TG were significantly correlated
with the values of diastolic blood pressure (r = 0.11, p,0.01),
HDL-c (r = 20.27, p,0.01), fasting glucose (r = 0.20, p,0.01),
TG (r = 0.77, p,0.01) and waist circumference (r = 0.20, p,0.01).
Moreover, levels of postprandial AUC of TRL were significantly
correlated with the values of diastolic blood pressure (r = 20.13,
p,0.01), HDL-c (r = 20.25, p,0.01), TG (r = 0.58, p,0.01),
fasting glucose (r = 0.16, p,0.01) and waist circumferen-
ce(r = 0.15, p,0.01). Hypolipidemic drugs (statins or fibrates)
were not significantly correlated with fasting TG and the AUC of
TG (all p.0.05).
In stepwise multiple linear regression analysis with the AUC of
triglycerides as the dependent variable, only fasting triglycerides,
fasting glucose and waist circumference appeared as significant
(P,0.05) contributors. The multiple regression (R) was 0.77, and
fasting triglycerides showed the greatest effect on AUC of
triglyceride (Table 4).
To explore the effect of basal hypertriglyceridemia on
postprandial metabolism, patients were divided into two groups
according to the presence or abscence of basal hypertriglyceride-
mia. In patients with high fasting triglycerides (TG $150 mg/dL),
the AUC and iAUC of TG were significantly greater
(6416461169 vs 364036501, p,0.001; and 1754861083 vs
122296324, p = 0.001, respectively) than in the group of patients
with fasting TG,150 mg/dL.
The influence of the different MetS factors still remained
statistically significant (p,0.001) when we analyzed the AUC of
TG on those patients without high TG at the basal point, but not
on those patients with basal hypertriglyceridemia (Table 5).
Discussion
In the present study we investigated the effect of a fatty meal on
postprandial lipid metabolism in patients with coronary artery
disease. We showed that MetS and the number of its components
influence the degree of postprandial lipemic response. Specifically,
postprandial AUC of TG showed a progressively unfavorable
increase from one component to five in our population. However,
this effect was attenuated when the population was divided into
two groups according to the presence or absence of basal
hypertriglyceridemia. Thus, only those patients without high
fasting TG remained a statistically significant influence.
Recently, it has been established that the presence of higher
number of components of MetS is associated with an increase in
subclinical atherosclerosis, and incidence and mortality of CHD.
Teramura et al. reported that intima-medial thickness was
significantly higher in subjects with MetS and increased with the
number of coexisting components of MetS, compared with those
without MetS [17]. Furthermore, a prospective cohort study
including 6255 subjects, showed how CHD and CVD mortality
were both influenced by the number of MetS components [20]. In
the same context, Sattar et al. observed that men presenting four
or five MetS traits had a 3.7-fold increase in risk for CHD and a
24.5-fold increase for diabetes compared with men with none [19].
However, the mechanisms underlying this fact are still unknown.
Although it is generally accepted that the main pathogenic
mechanism underlying the development of cardiometabolic
changes in patients with MetS relies on insulin resistance, other
mechanisms could influence the increased risk of CVD associated
to MetS. While the independence of the association and causality
has not been fully established, postprandial TG concentrations
have emerged as a clinically significant CVD risk factor following
the results of several prospective studies [25]. In our study, patients
with an increased number of MetS components showed higher
levels of postprandial TG, confirmed by AUC and iAUC of TG.
This deterioration in postprandial lipid metabolism associated with
the increase number of MetS components may favor a higher risk
of atherogenesis.
Previous studies have explored the mechanisms underlying the
relation between postprandial lipid metabolism and the increased
risk of atherogenesis [26,27]. High levels of postprandial triglyc-
erides have been reported to correlate with high remnant
cholesterol in individuals in the general population [4], and, in
addition, it has been proposed that in those situations where the
liver induces an overproduction of VLDL, such as central obesity,
metabolic syndrome, type 2 diabetes mellitus and familial
combined hypercholesterolemia, VLDL and chylomicrons cata-
bolic mechanisms are saturated [12,28–30]. These mechanisms
cause the accumulation of VLDL and chylomicron remnants [31–
Table 4. Multiple linear regression coefficients1 to predict AUC of triglycerides.
Parameter Unstandardized Coefficients Standardized Coefficients Sig.
B Std. Error Beta
Fasting TG 228.49 6.68 0.752 ,0.001
Fasting Glucose 29.41 11.05 0.059 0.008
Waist Circumference 85.78 37.43 0.051 0.02
Predictive variables tested by stepwise method: fasting triglycerides (mg/dL), fasting glucose (mg/dL), waist circumference (cm), fasting HDL-c (mg/dL), systolic and
diastolic Blood (mmHg).
1(Constant) = 2163.28. (R2) = 0.602.
doi:10.1371/journal.pone.0096297.t004
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33], a lower concentration of HDL-c and the activation of
leukocytes and endothelial cells by the remnants and fatty acids
[34,35]. At this stage, postprandial remnant lipoproteins would
penetrate the vessel wall and monocytes would catch them,
inducing the formation of foam cells [36]. Although it is generally
accepted that the main pathogenic mechanism underlying the
development of metabolic changes in patients with MetS relies on
insulin resistance, a large body of evidence supports the concept
that increased oxidative stress and a state of chronic low-level
inflammation may have important roles in MetS-related manifes-
tations [37]. In this way, the formation of oxidized reactive species
and oxidized remnant lipoproteins would also contribute to
endothelial dysfunction and the development of coronary artery
disease [37]. In this regard, we have recently demonstrated the
relationship between the number of MetS components and the
degree of oxidative stress in MetS patients [38].
Previous evidence carried out in healthy population has
suggested a significant linear trend between increasing numbers
of MetS components and magnitude of postprandial lipemia in
112 healthy subjects [25]. Nevertheless, to our knowledge, our
study is the first one to show that in non-hypertriglyceridemic
coronary patients. Another important feature underlying MetS is
atherogenic dyslipidemia, defined as a rise in triglycerides and
small LDL particles and low HDL-c [39]. In this regard, we have
observed that patients with at least three MetS components have
higher ApoB plasma levels and lower HDL-c and ApoA1 plasma
levels in all blood drawn during the postprandial state, as well as a
positive relationship with AUC of ApoB and a negative
relationship with AUC of HDL-c and ApoA1. All of these
abnormalities have been implicated as being independently
atherogenic [14].
Although baseline TG has been previously proposed in different
studies as the major determinant of postprandial lipemia [7–10], in
our study the involvement of other factors were also statistically
significant. Thereby, the stepwise multiple linear regression
analysis with the AUC of triglycerides as the dependent variable,
showed that fasting TG, fasting glucose and waist circumference
appeared as significant independent contributors, with fasting TG
as the major contributors (see Table 4).To avoid the influence of
high levels of fasting TG on postprandial response, patients were
divided in our study into two groups on the basis of their fasting
TG concentrations. In hypertriglyceridemic patients, the AUC
and iAUC of TG were significantly greater than in the group of
normotriglyceridemic patients, according to previous data report-
ed [40]. Besides, the influence of number of MetS components on
AUC of TG remained statistically significant in those patients
without high fasting TG but not in those patients with basal
hypertriglyceridemia. This feature may be related to the fact that
in an already disturbed background, as suggested by a fasting
hypertriglyceridemia, the postprandial lipid metabolism is altered,
and cannot be impaired further by the presence of MetS traits.
However, in patients that are not hypertriglyceridemic, the
addition of different metabolic syndrome criteria can progressively
worsen the efficient management of a fat meal, suggesting, from a
clinical point of view, that MetS subjects with normotriglycer-
idemia would obtain a higher benefit on the size of postprandial
lipemia controlling MetS components than those with hypertri-
glyceridemia.
Despite the great strength of our study given the population size
and the standardized methodology used, there were some
limitations. The cross-sectional study design limited our ability to
make an inference about the casual relationship between MetS
components and postprandial parameters. However, it will be
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that the CORDIOPREV study is an ongoing prospective,
randomized, opened and controlled trial with a mean proposed
follow-up of 5 years. Moreover, it would be interesting to study
whether those patients with an increased number of MetS
components and higher postprandial lipemia have more cardio-
vascular events in the future.
In summary, our study shows that the existence of MetS
influences the postprandial response of carbohydrates and lipids in
patients with coronary heart disease. In non-hypertriglyceridemics
patients, the magnitude of postprandial response is related to the
number of MetS components altered. Fasting triglycerides are the
major contributors to the postprandial triglycerides levels. Our
findings imply the need for intensive control of MetS components
to decrease the cardiovascular risk.
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